Updated: January 22, 2026
How to Find Elahere in Stock Near You (Tools + Tips)
Author
Peter Daggett

Summarize with AI
- Step 1: Confirm Your FRα Eligibility First
- Step 2: Work With Your Oncologist and ELAHERE Support Services
- Step 3: Locate an Infusion Center That Administers Elahere
- Step 4: Ask About Specialty Pharmacy Partners
- Step 5: Use medfinder to Find Facilities Near You
- What to Tell the Infusion Center When You Call
- What About Eye Care Monitoring?
- Summary: Your Action Plan
Looking for Elahere (mirvetuximab soravtansine-gynx) near you? Here are the best tools and strategies to locate this specialty cancer infusion in 2026.
Finding Elahere (mirvetuximab soravtansine-gynx) requires a different approach than filling a standard prescription. Because it's a specialty IV infusion for platinum-resistant ovarian cancer, Elahere is not available at your local pharmacy. But that doesn't mean it's out of reach. Here's what you need to know to locate Elahere near you in 2026.
Step 1: Confirm Your FRα Eligibility First
Before you can receive Elahere, you must have a confirmed positive result on the VENTANA FOLR1 (FOLR-2.1) RxDx Assay — the FDA-approved companion diagnostic test. This test checks whether your tumor expresses folate receptor alpha (FRα) at levels sufficient to qualify for Elahere treatment. About 35% of ovarian cancer patients have high FRα expression. If you haven't been tested, ask your oncologist about it before pursuing any of the steps below.
Step 2: Work With Your Oncologist and ELAHERE Support Services
AbbVie offers a dedicated support program called ELAHERE Support Services (ESS). Once your oncologist prescribes Elahere, enroll in ESS immediately. ESS assigns you a Case Manager who will:
Work with your insurance to submit prior authorization documentation
Help identify specialty pharmacies or infusion centers that can dispense and administer Elahere
Guide you to financial assistance options including co-pay cards and the Patient Assistance Program (PAP)
Enroll by calling 1-833-ELAHERE (1-833-352-4373) or by having your oncologist submit the ESS enrollment form.
Step 3: Locate an Infusion Center That Administers Elahere
Because Elahere requires IV administration in a clinical setting, you'll need to find an oncology infusion center. Here are the best places to start:
NCI-designated cancer centers: These major cancer centers have the most experience with ADCs like Elahere and typically have the infrastructure in place to handle companion diagnostic testing and complex infusion scheduling.
Academic medical centers: University hospitals and teaching hospitals often have gynecologic oncology departments familiar with Elahere.
Community oncology practices: Many community oncology clinics now administer specialty biologics like Elahere. Ask your oncologist if their practice has the capability.
Hospital-based infusion centers: Many hospitals with oncology departments offer infusion suites where Elahere can be prepared and administered.
Step 4: Ask About Specialty Pharmacy Partners
Elahere is distributed through specialty pharmacies that supply oncology infusion centers. Your infusion center's pharmacy team handles ordering and preparation. If your current center doesn't stock Elahere, ask the ESS Case Manager to help identify facilities in your area that do.
Step 5: Use medfinder to Find Facilities Near You
Navigating the specialty pharmacy landscape on your own can be overwhelming. medfinder is a paid service that calls facilities near you on your behalf to find out which ones can fill your Elahere prescription. Instead of spending hours calling cancer centers and specialty pharmacies yourself, medfinder does the legwork — and texts you the results.
What to Tell the Infusion Center When You Call
When calling cancer centers or infusion clinics directly, have this information ready:
Your diagnosis: FRα-positive, platinum-resistant epithelial ovarian cancer (or fallopian tube / peritoneal cancer)
Your FRα test result (positive)
Medication name: mirvetuximab soravtansine-gynx (Elahere), 6 mg/kg IV every 3 weeks
Your insurance information and whether prior authorization has been initiated
What About Eye Care Monitoring?
One unique logistical aspect of Elahere treatment: you'll need access to an eye care provider (optometrist or ophthalmologist) before and throughout treatment. Elahere carries a boxed warning for ocular toxicity, and FDA requires an ophthalmic exam before your first dose, then every other cycle for the first 8 cycles. When locating an infusion center, ensure it has easy access to eye care — either within the same health system or nearby.
Summary: Your Action Plan
Confirm FRα-positive status with your oncologist
Enroll in ELAHERE Support Services (1-833-352-4373)
Identify NCI cancer centers or community oncology practices near you that administer Elahere
Use medfinder to find facilities near you faster
Establish eye care monitoring with an ophthalmologist or optometrist near your infusion center
Still have questions about access? Read our related article: Why Is Elahere So Hard to Find? [Explained for 2026].
Frequently Asked Questions
Elahere infusions are administered at oncology infusion centers, NCI-designated cancer centers, academic medical centers, and community oncology clinics equipped for specialty biologic infusions. Call your oncologist or enroll in ELAHERE Support Services (1-833-352-4373) to identify facilities near you.
Insurance prior authorization for Elahere typically takes 2-4 weeks. If you qualify for ELAHERE Support Services' Patient Assistance Program, access timelines can vary. Your ESS Case Manager can help expedite the process and identify the fastest path to treatment.
Not all infusion centers are equipped to administer Elahere. It requires specialized oncology staff, proper cold-chain storage, and coordination with a specialty pharmacy. Ask the infusion center specifically whether they have experience with mirvetuximab soravtansine-gynx (Elahere) before scheduling.
Yes. Elahere has a boxed warning for ocular toxicity. FDA requires a complete ophthalmic examination — including visual acuity and slit lamp exam — before your first dose, every other cycle for the first 8 cycles, and as clinically needed. Prophylactic steroid and lubricating eye drops are also required during treatment.
Yes. Enrolling in ELAHERE Support Services (1-833-352-4373) connects you with a Case Manager who can help identify specialty pharmacies and infusion centers in your area that can administer Elahere, in addition to helping navigate insurance coverage.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Elahere also looked for:
More about Elahere
35,948 have already found their meds with Medfinder.
Start your search today.





